Australia’s biggest in vitro fertilization company is targeting the U.K. in the latest phase of its overseas expansion, but says it won’t join the rush of companies opening clinics in China where health-care spending is tipped to surge.
via WSJ.com: US Business http://ift.tt/1whTItv
via WSJ.com: US Business http://ift.tt/1whTItv
Nessun commento:
Posta un commento